Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families.

Documenti analoghi

• Double heterozygotes for the Ashkenazi founder mutations in BRCA1 and BRCA2 genes.
  di: Friedman, E, et al.
  Pubblicazione: (1998)
• Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population
  di: Simchoni, Sharon, et al.
  Pubblicazione: (2006)
• Incidence of non-founder BRCA1 and BRCA2 mutations in high risk Ashkenazi breast and ovarian cancer families
  di: Kauff, N, et al.
  Pubblicazione: (2002)
• Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and Non-Ashkenazi men with breast cancer: Evidence from 261 cases in Israel, 1976-1999
  di: Chodick, Gabriel, et al.
  Pubblicazione: (2007)
• Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer
  di: Hodgson, S., et al.
  Pubblicazione: (1999)